Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3763990015 | Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3763991016 | Lamivudine 30 mg and nevirapine 50 mg and stavudine 6 mg orodispersible tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 3 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Count of base of active ingredient | trois | false | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 3 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | a une forme pharmaceutique (attribut) | comprimé orodispersible | true | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | est un(e) (attribut) | Lamivudine and nevirapine and stavudine only product in oromucosal dose form | true | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator value (attribute) | six | false | Inferred relationship | Some | 1 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has basis of strength substance (attribute) | Lamivudine (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has precise active ingredient | Lamivudine (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator value (attribute) | 30 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has precise active ingredient | Stavudine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has basis of strength substance (attribute) | Nevirapine (substance) | true | Inferred relationship | Some | 3 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator value (attribute) | 50 (qualifier value) | false | Inferred relationship | Some | 3 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has basis of strength substance (attribute) | Stavudine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has precise active ingredient | Nevirapine (substance) | true | Inferred relationship | Some | 3 | |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | est un(e) (attribut) | Product containing lamivudine and nevirapine and stavudine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | a pour principe actif (attribut) | Stavudine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | a pour principe actif (attribut) | Lamivudine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | a pour principe actif (attribut) | Nevirapine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | a une forme pharmaceutique (attribut) | Dispersible tablet | false | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | est un(e) (attribut) | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | est un(e) (attribut) | Lamivudine- and nevirapine- and stavudine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | a une forme pharmaceutique (attribut) | Tablet for oral suspension | false | Inferred relationship | Some | ||
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | est un(e) (attribut) | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
Description inactivation indicator reference set
FHIR